Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids
Samuel Obeng, Shyam H. Kamble, Morgan E. Reeves, Luis F. Restrepo, Avi Patel, Mira Behnke, Nelson J.-Y. Chear, Surash Ramanathan, Abhisheak Sharma, Francisco León, Takato Hiranita, Bonnie A. Avery, Lance R. McMahon, Christopher R. McCurdy
Cite this: J. Med. Chem. 2020, 63, 1, 433-439 Publication Date:December 13, 2019
https://doi.org/10.1021/acs.jmedchem.9b01465
Gives Ki values at opioid receptors and adrenergic receptors for several major Kratom alkaloids. The summary:
Corynantheidine half life 6min, Ki 118 nM at mu, 1910 nM at kappa, 41 nM at alpha-1D.
9-Hydroxycorynantheidine, half life 180 min, Ki 105 nM at mu.
Mitragynine half life 20 min, Ki 161 nM at mu, 198 nM at kappa, 1300-9600 nM at the various adrenergic receptors. (1A > 2C > 1B = 2A > 1B > 2B)
7-Hydroxymitragynine half life 170 min, Ki 7 nM at mu, 74 nM at kappa, 236 nM at delta.
Speciociliatine half life 42 min, Ki 54.5 nM at mu, 116 nM at kappa.
Further studies con-ducted to investigate the in vivo functional effects of mitragynine, 7-hydroxymitragynine, and speciociliatine using the hotplate test at 52 ± 0.1 ̊C revealed that 7-hydroxymitragynine and speciociliatine produced maximum response (100 % MPE) with 7-hydroxymitragynine being more potent than speciociliatine and morphine but less potent than fentanyl. Speciociliatine had a similar potency to morphine and mitragynine had the least efficacy among the compounds testedat the highest dose assayed. The antinociceptive effect of 7-hydroxymitragynine was reversed by 0.1 mg/kg naltrexone which suggest that 7-hydroxymitragynine may be acting through the MOP as demonstrated by the binding and in vitro functional as-says. Speciociliatine had antinociceptive effects at 10mg/kg; however, this dose produced lethality in 5/21 rats tested, indicating a narrow therapeutic window. Since the ED50 of speciociliatine to produce antinociception is close to its LD50 value, in this acute antinociception assay (i.e., hotplate test) it was not feasible to evaluate the extent to which the antinociception observed was due to activation of opioid receptors by conducting antagonism tests with opioid sub-type antagonists. In addition, speciociliatine similar to U69593 produced hypothermia but not 7-hydroxymitragynineormitragynine. Collectively, this profile of in vivo activity may indicate that speciociliatine is acting, at least in part, through non-opioids receptors.